Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Moderna Rallies On Merck Collaboration: Can Drugmaker Replace COVID Vaccine Revenue?

In late 2020, when the world was searching for a vaccine or cure for COVID-19, the price action in Moderna Inc (NASDAQ: MRNA) was discussed frequently on Benzinga's PreMarket Prep show.

Benzinga

Ministry kicks off Pfizer jabs for toddlers

The Ministry of Public Health kicked off the first round of Covid-19 vaccinations for the youngest demographic in the country on Wednesday.

Bangkok Post

How this Brazilian doc got nearly every person in her city to take a COVID vaccine

Dr. Gabriela Kucharski's city of Toledo had virtually no vaccines. And it's a bastion of support for Brazil's vaccine skeptic president. Here's why that didn't matter.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA authorizes Covid vaccine boosters for children five and above

Moderna vaccine has been approved for children six years and older, while children as young as five can get Pfizer

The Guardian - US

FDA authorizes COVID omicron boosters for kids 5 and up

COVID-19 vaccine makers Pfizer Inc. and Moderna Inc. received U.S. regulatory clearances for their omicron-targeted boosters for children as young as 5.

Tribune News Service

Omicron boosters for kids 5-12 are cleared by the CDC

Tweaked boosters rolled out for Americans 12 and older last month, modified to target today's most common and contagious variant. The latest move may expand protection before an expected winter wave.

WEKU

FDA clears updated COVID boosters for kids as young as 5

The U.S. is about to offer updated COVID-19 booster shots to kids as young as 5

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Income Plus Low Volatility Makes This Fund A Safe Haven

Are you looking for a relatively safe mutual fund haven amid current market carnage? Check out Madison Covered Call & Equity Income Fund (MENYX).

Investors Business Daily

Feds rebuke Florida surgeon general’s advice to young men on COVID vaccine

ORLANDO, Fla. — The Food and Drug Administration on Monday responded to the results of Florida Surgeon General Joseph Ladapo’s analysis of COVID-19 data that he says point to a risk for some men who get the shot.

Orlando Sentinel

Check Out What Whales Are Doing With PFE

Someone with a lot of money to spend has taken a bearish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Youngest children to get Covid jabs

The Ministry of Public Health will inoculate young children aged six months to four years old with the Pfizer Covid-19 vaccine starting next Wednesday.

Bangkok Post

Pfizer COVID vaccine clears Japan panel for use with young children

A Japanese health ministry panel on Wednesday recommended approving Pfizer Inc's COVID-19 vaccine for children as young as six months old.

Reuters

‘Like copying a Louis Vuitton handbag’: big pharma hits out at Africa’s replica Covid vaccine

Knowledge-sharing hub in Cape Town reverse engineered the Moderna vaccine, but future of the initiative to reduce inequity remains unsure

The Guardian - UK

Coronavirus (booster) FAQ: Can it cause a positive test? When should you get it?

There is a lot of information about coronavirus vaccines out there, and some of it seems vague or contradictory. We talked to experts to help answer some of the most common and confusing questions.

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Panel rejects $1M payouts to inmates given vaccine overdoses

A state board has rejected claims for $1 million payments for 52 prison inmates who were given six times the proper dose of COVID-19 vaccines last year

Investors Business Daily

Myovant Sciences Rockets After Rejecting Lowball Sumitovant Biopharma Takeover Bid

Myovant Sciences turned down a takeover bid from majority shareholder Sumitovant Biopharma on Monday, and MYOV stock skyrocketed.

Benzinga

What Are Whales Doing With Pfizer

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 11 strange trades.

StockNews.com

3 Safe Stocks You'll Want to Have Exposure to in 2022

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Woman left with 'debilitating' lesions and unable to eat for months after Covid jab

Doctors struggled to diagnose the root of the cause due to lack of reporting, after an Australian woman suffered from "debilitating" lesions on her tongue after receiving a Pfizer Covid vaccine

ABC News

All the latest COVID news and case numbers from around the states and territories

Here's a quick wrap of the latest COVID-19 news and case numbers from each Australian jurisdiction from the past week.

AAP

Doctor's warning on axing isolation rules

The head of the AMA has blasted state and territory leaders advocating for scrapping COVID isolation requirements, saying they're putting lives at risk.

ABC News

Pfizer COVID vaccine approved for all children aged over six months old

The Therapeutic Goods Administration approves Pfizer's paediatric dose of its COVID vaccine for children aged between six months and five years old.

AAP

Interim tick for Pfizer infant booster

The Therapeutic Goods Administration has given provisional approval for Pfizer's COVID-19 booster to be used in children aged six months to five years.

ABC News

Pfizer pays $179m for Brisbane company behind smartphone app that claims to diagnose COVID

Recent studies had shown the app had a 92 per cent success rate in diagnosing the virus among symptomatic patients, but more clinical trials were needed for it to gain regulatory approval.

The Independent UK

Pfizer seeks to expand omicron booster to 5- to 11-year-olds

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11

1 … 32 33 34 35

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.